Results

Total Results: 4,542 records

Showing results for "pregnant women".

221. Antidepressant Treatment of Depression During Pregnancy and the Postpartum Period (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/depression-pregnancy-postpartum_executive.pdf
     July 01, 2014 - Framework 1a relates to pregnant women with depression who receive treatment. … The outcomes considered differed from those considered for pregnant women. … Evidence for other health outcomes in pregnant women is missing. … Why Pregnant Women Deserve Drug Trials. Body Politic [Blog]. … Research involving pregnant women or fetuses [45 CFR Part 46B Section 204].

222. Women | Digital Healthcare Research
     digital.ahrq.gov/population/women
     January 01, 2024 - Women An AI-Directed CDS Tool to Reduce Iron Deficiency Anemia in Pregnancy: A Randomized Controlled Trial (AID-IDA Trial) Description This study will develop and establish the efficacy of an actionable predictive model to identify pregnant individuals at high risk for postpar…

223. Headaches in Pregnancy | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/topic-nomination-31814
     September 05, 2018 - Additionally, pregnant women more commonly suffer from migraines and tension headaches which can be unpleasant … women. … women with these conditions. … women may experience, to improve their overall health and wellbeing. … women with headaches.

224. USPSTF Seeks Comment on Its Draft Recommendation Statement on Low-Dose Aspirin for Women at High Risk for Preeclampsia (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/asprpregdraftbulletin.pdf
     May 05, 2014 - This recommendation applies to pregnant women who are at high risk for preeclampsia and who don’t show … Preeclampsia is a complex condition that occurs in pregnant women and is marked by a rise in blood pressure … “The good news is that pregnant women who are at high risk for developing preeclampsia can take a low … "Only a small percentage of pregnant women are at high risk for preeclampsia,” says Task Force chair … “Before taking aspirin, pregnant women should talk to their doctor or nurse to determine their risk

225. Archived: Final Recommendation Statement: Screening for Depression in Adults | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/depression-in-adults-screening
     January 26, 2016 - Depression is also common in postpartum and pregnant women and affects not only the woman but her child … The reported effect was smaller (18%) and did not reach significance in the trial of pregnant women but … All 10 trials of CBT or CBT-related interventions, including the 2 trials in pregnant women, showed an … The magnitude of effect in pregnant women was similar to that in postpartum women. … of antidepressants in pregnant women whose depression status in either or both treatment groups was

226. SRDR - Systematic Review Data Repository |
     srdr.ahrq.gov/projects/1603
     February 16, 2021 - Byun SW., Park YJ., Hur SY. 2016 Metronidazole to prevent preterm delivery in pregnant women … women. … 2002 Wet smear compared with gram stain diagnosis of bacterial vaginosis in asymptomatic pregnant … women. … women with symptoms suggestive of infection.

227. Final Research Plan: Healthy Weight and Weight Gain In Pregnancy: Behavioral Counseling Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/healthy-weight-and-weight-gain-during-pregnancy-behavioral-counseling-interventions
     July 26, 2018 - Do interventions to limit excess gestational weight gain improve health outcomes among pregnant women … women and their infants?     … What are the harms of interventions to limit excess gestational weight gain among pregnant women and … Category Included Excluded Populations Pregnant women with normal and high BMI and women … women with gestational diabetes mellitus; women with pre-existing diabetes Interventions

228. Evidence Summary: Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/iron-deficiency-anemia-in-pregnant-women-screening-and-supplementation
     August 20, 2024 - Prevalence of iron deficiency in first trimester, nonanemic pregnant women. … Routine Iron Supplementation and Screening for Iron Deficiency Anemia in Pregnant Women: A Systematic … Gaps in evidence regarding iron deficiency anemia in pregnant women and young children: summary of US … Impact of prophylactic iron supplementation in healthy pregnant women on maternal iron status and birth … Iron status markers in nonanemic pregnant women with and without iron supplementation.

229. CHIPRA 233: Section 3, Table 2, FDA Pregnancy Category Rating (pdf file)
     www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-hrob-section-3-table-2.pdf
     August 08, 2018 - failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant … women. … women despite potential risks. … women despite potential risks. … women clearly outweigh potential benefits.

230. CHIPRA 233: Section 3, Table 2, FDA Pregnancy Category Rating (pdf file)
     www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-hrob-section-3-table-2.pdf
     August 08, 2018 - failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant … women. … women despite potential risks. … women despite potential risks. … women clearly outweigh potential benefits.

231. CHIPRA 233: Section 3, Table 2, FDA Pregnancy Category Rating (pdf file)
     www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-hrob-section-3-table-2.pdf
     August 08, 2018 - failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant … women. … women despite potential risks. … women despite potential risks. … women clearly outweigh potential benefits.

232. CHIPRA 233: Section 3, Table 2, FDA Pregnancy Category Rating (pdf file)
     www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-hrob-section-3-table-2.pdf
     August 08, 2018 - failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant … women. … women despite potential risks. … women despite potential risks. … women clearly outweigh potential benefits.

233. CHIPRA 233: Section 3, Table 2, FDA Pregnancy Category Rating (pdf file)
     www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-hrob-section-3-table-2.pdf
     August 08, 2018 - failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant … women. … women despite potential risks. … women despite potential risks. … women clearly outweigh potential benefits.

234. CHIPRA 233: Section 3, Table 2, FDA Pregnancy Category Rating (pdf file)
     www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-hrob-section-3-table-2.pdf
     August 08, 2018 - failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant … women. … women despite potential risks. … women despite potential risks. … women clearly outweigh potential benefits.

235. CHIPRA 233: Section 3, Table 2, FDA Pregnancy Category Rating (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-hrob-section-3-table-2.pdf
     August 08, 2018 - failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant … women. … women despite potential risks. … women despite potential risks. … women clearly outweigh potential benefits.

236. Disposition of Comments Report for Treatment of Depression During Pregnancy and the Postpartum Period (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-pregnancy-postpartum_disposition-comments.pdf
     July 08, 2014 - The outcomes considered differed from those considered for pregnant women. … women Evidence for other health outcomes in pregnant women is missing.” … women Evidence for other health outcomes in pregnant women is missing.” … women Evidence for other health outcomes in pregnant women is missing.” … women receiving antidepressants for mixed or unreported reasons and compared with pregnant women not

237. Disposition of Comments Report for Treatment of Depression During Pregnancy and the Postpartum Period (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/depression-pregnancy-postpartum_disposition-comments.pdf
     July 08, 2014 - The outcomes considered differed from those considered for pregnant women. … women Evidence for other health outcomes in pregnant women is missing.” … women Evidence for other health outcomes in pregnant women is missing.” … women Evidence for other health outcomes in pregnant women is missing.” … women receiving antidepressants for mixed or unreported reasons and compared with pregnant women not

238. Smoking Cessation Interventions During Pregnancy and the Postpartum Period | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/smoking-pregnancy-infants/research-protocol
     December 01, 2019 - Factors associated with smoking cessation among U.S. pregnant women. … [Smoking and exposure to tobacco smoke among pregnant women in Ecuador]. … [Smoking cessation in the pregnant woman: descriptive study in Limousin]. … [Correlates of smoking in pregnant women in six Brazilian cities]. … [How can we help pregnant women stop smoking?].

239. Preventive Service: Alcohol Misuse Screening & Behavioral Counseling Intervention (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/prevention-chronic-care/healthier-pregnancy/documents/alcohol-misuse-provider-fact-sheet.pdf
     January 01, 2014 - The CDC reports that 1 in 6 (roughly 17%) adults (includes pregnant women subgroup) are asked by their … women are T- ACE, TWEAK, and 4-Ps . … Substance Abuse Treatment Services for Pregnant Women: Psychosocial and Behavioral Approaches. … Alcohol-screening instruments for pregnant women. Alcohol Res Health; 25(3):204-9. 12 U.S. … women enhance their skills and improve care for women and infants.

240. Topic Suggestion Description | Effective Health Care Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/protocols-pre-existing
     June 03, 2021 - There is a paucity of evidence-based protocols targeted to pregnant women as they are not typically included